| Name | Title | Contact Details |
|---|---|---|
Rhonda Clark |
Medicare Chief Growth Officer | Profile |
Timothy Glover |
National Broker Sales Director | Profile |
Eric Hoernemann |
Talent Program Director | Profile |
Patricia Cruzalvarez |
Staff VP Human Resources | Profile |
David Jones |
CMO, Director of Medical Operations | Profile |
E*Health Line.com, Inc. is a Sacramento, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Clemente Ambulance is a Struthers, OH-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
In 1969, AvMed began in South Florida as Aviation Medicine to serve the growing airline industry by providing pilot physicals. Today, with offices in every major metropolitan area of the state, AvMed aims to inspire its membership of 300,000 Floridians to “Embrace better health.” AvMed provides Medicare Advantage coverage in Broward and Miami-Dade counties, Individual and Family coverage in Broward, Miami-Dade, and Palm Beach counties and Commercial coverage in more than 30 counties across the state. Major employer clients have been partners for decades, a testament to AvMed`s culture of service, which consistenly ranks above statewide peers.
Bionor Pharma is a leading biotechnology company advancing the first therapeutic vaccine towards a functional cure for HIV. The company`s focus is the research and development of peptide-based vaccines against viral diseases, primarily HIV. Bionor Pharma`s most advanced product candidate is Vacc-4x, which is also the most advanced therapeutic vaccine in the HIV space and has demonstrated a reduction of viral load in a large, randomized, controlled Phase II trial, as well as safety and tolerability. Pharma`s current clinical focus is to explore whether Vacc-4x, used with other medicines as a combination therapy, can reduce the viral load even further, and the company, through collaboration with Celgene, is investigating Vacc-4x and the HDAC inhibitor romidepsin in the REDUC study. In May 2015, Bionor Pharma announced promising results from an interim analysis of Part B of the REDUC study. In the study, Vacc-4x and romidepsin are explored as a possible treatment regimen to reduce the persistent latent viral reservoir in HIV infected patients on anti-retroviral treatment. Results are expected in the second half of 2015. Bionor Pharma is headquartered in Oslo, Norway, with offices in Copenhagen and New York.
Eurogentec North America is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.